Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,500.00
(
0.43%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
108.42
(
1.26%
)
Bitcoin
68,573.43
(
-0.41%
)
News Focus
News Focus
Post# of 257366
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

pcrutch

Send PM Follow Ignore
Followers 68
Posts 2711
Boards Moderated 0
Alias Born 02/25/2010

pcrutch

Re: None

Tuesday, 03/20/2012 2:47:25 PM

Tuesday, March 20, 2012 2:47:25 PM

Post# of 257366
REGN's Phase 2 results from their PCSK9 drug, REGN727, will be the main clinical results presented at the ACC's late-breaking trials session meeting next week.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today